Cover Image
Market Research Report

Global Organ Transplant Market By Type, By Sex, By Product, By Organ, By Types of Transplant, By Region, Forecast & Opportunities, 2025

Published by TechSci Research Product code 934756
Published Content info 119 Pages
Delivery time: Inquiry
Price

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Back to Top
Global Organ Transplant Market By Type, By Sex, By Product, By Organ, By Types of Transplant, By Region, Forecast & Opportunities, 2025
Published: May 1, 2020 Content info: 119 Pages
Description

Global organ transplant market is expected to grow at a robust CAGR during the forecast period. Organ transplantation is basically the replacement of damaged or missing organs in the body with healthy ones. The market for organ transplant is driven by the growing old-age segment cross the world along with increasing cases of organ failures. Additionally, alcohol consumption has increased over the years, which usually damages the liver; thereby, positively impacting the organ transplant market. However, the market might be restrained due to the high cost of the organs that needs to be transplanted as they are really expensive, and the cost varies from country to country.

The global organ transplant market is segmented on the basis of type, sex, product, organ, types of transplant and region. The organ segment is further divided into lung, heart, liver, pancreas, intestine, kidney and others. Among these, kidney transplant is anticipated to account for the largest share in the market until 2025 as it has been proven to be the most successful transplant in the world. Also, increasing prevalence of renal diseases, globally is driving the growth of the segment.

Regionally, North America occupied the lion's share in global organ transplant market in 2019 by virtue of the increasing cases of organ failures and the ability of the region's economy to provide enough funds to carry out organ transplantations. However, Asia-Pacific is anticipated to be one of the fastest growing regions as developing economies like India and China are still getting accustomed to organ transplants.

Leading players in the global organ transplant market include Novartis, Pfizer, Transmedics, Organ Recovery Systems, Sanofi, Transonic Systems Inc., XVIVO Perfusion, Transplant Biomedicals, Pharmaceuticals A/S, Organ Assist B.V, Essential Pharmaceuticals LLC., BioLife Solutions, Inc., Lifeline Scientific, 21st Century Medicine, Preservation solutions Inc., GE Healthcare, Sandor, Glaxosmith Kline, AstraZeneca, Amgen, etc.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global organ transplant market.
  • To classify and forecast global organ transplant market based on type, sex, product, organ, types of transplant, region and company.
  • To identify drivers and challenges for global organ transplant market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global organ transplant market.
  • To conduct pricing analysis for global organ transplant market.
  • To identify and analyze the profile of leading players operating in global organ transplant market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics, and presence of all major players across the globe.

TechSci Research calculated the market size of global organ transplant market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Organ transplant hospitals/clinics, laboratories, research institutes and other stakeholders
  • Pharmaceutical companies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to organ transplant
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global organ transplant market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Living-donor transplant

Dead donor transplant

  • Market, By Sex:

Male

Female

  • Market, By Product:

Immuno-suppressant Drugs

Organ preservation solution

Organ Care System

  • Market, By Organ:

Lung

Heart

Liver

Pancreas

Intestine

Kidney

Others

  • Market, By Types of Transplant:

Double Transplant

Single Transplant

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Russia
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global organ transplant market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Table of Contents
Product Code: 4670

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Organ Transplant Market

4. Voice of Customer

5. Executive Summary

6. Global Organ Transplant Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Living-donor transplant, Dead donor transplant)
    • 6.2.2. By Sex (Male, Female)
    • 6.2.3. By Product (Immuno-suppressant Drugs, Organ preservation solution, Organ Care System)
    • 6.2.4. By Organ (Lung, Heart, Liver, Pancreas, Intestine, Kidney and Others)
    • 6.2.5. By Types of Transplant (Double transplant, Single transplant)
    • 6.2.6. By Company (2019)
    • 6.2.7. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Organ Transplant Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Sex
    • 7.2.3. By Product
    • 7.2.4. By Organ
    • 7.2.5. By Types of Transplant
    • 7.2.6. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Organ Transplant Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Sex
        • 7.4.1.2.3. By Product
        • 7.4.1.2.4. By Organ
        • 7.4.1.2.5. By Types of Transplant
    • 7.4.2. India Organ Transplant Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Sex
        • 7.4.2.2.3. By Product
        • 7.4.2.2.4. By Organ
        • 7.4.2.2.5. By Types of Transplant
    • 7.4.3. Japan Organ Transplant Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Sex
        • 7.4.3.2.3. By Product
        • 7.4.3.2.4. By Organ
        • 7.4.3.2.5. By Types of Transplant
    • 7.4.4. South Korea Organ Transplant Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Type
        • 7.4.4.2.2. By Sex
        • 7.4.4.2.3. By Product
        • 7.4.4.2.4. By Organ
        • 7.4.4.2.5. By Types of Transplant
    • 7.4.5. Singapore Organ Transplant Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Type
        • 7.4.5.2.2. By Sex
        • 7.4.5.2.3. By Product
        • 7.4.5.2.4. By Organ
        • 7.4.5.2.5. By Types of Transplant
    • 7.4.6. Australia Organ Transplant Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Type
        • 7.4.6.2.2. By Sex
        • 7.4.6.2.3. By Product
        • 7.4.6.2.4. By Organ
        • 7.4.6.2.5. By Types of Transplant

8. Europe Organ Transplant Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Sex
    • 8.2.3. By Product
    • 8.2.4. By Organ
    • 8.2.5. By Types of Transplant
    • 8.2.6. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Organ Transplant Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Sex
        • 8.4.1.2.3. By Product
        • 8.4.1.2.4. By Organ
        • 8.4.1.2.5. By Types of Transplant
    • 8.4.2. Germany Organ Transplant Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Sex
        • 8.4.2.2.3. By Product
        • 8.4.2.2.4. By Organ
        • 8.4.2.2.5. By Types of Transplant
    • 8.4.3. United Kingdom Organ Transplant Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Sex
        • 8.4.3.2.3. By Product
        • 8.4.3.2.4. By Organ
        • 8.4.3.2.5. By Types of Transplant
    • 8.4.4. Italy Organ Transplant Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Type
        • 8.4.4.2.2. By Sex
        • 8.4.4.2.3. By Product
        • 8.4.4.2.4. By Organ
        • 8.4.4.2.5. By Types of Transplant
    • 8.4.5. Russia Organ Transplant Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Type
        • 8.4.5.2.2. By Sex
        • 8.4.5.2.3. By Product
        • 8.4.5.2.4. By Organ
        • 8.4.5.2.5. By Types of Transplant
    • 8.4.6. Spain Organ Transplant Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Type
        • 8.4.6.2.2. By Sex
        • 8.4.6.2.3. By Product
        • 8.4.6.2.4. By Organ
        • 8.4.6.2.5. By Types of Transplant

9. North America Organ Transplant Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Sex
    • 9.2.3. By Product
    • 9.2.4. By Organ
    • 9.2.5. By Types of Transplant
    • 9.2.6. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Organ Transplant Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Sex
        • 9.4.1.2.3. By Product
        • 9.4.1.2.4. By Organ
        • 9.4.1.2.5. By Types of Transplant
    • 9.4.2. Mexico Organ Transplant Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Sex
        • 9.4.2.2.3. By Product
        • 9.4.2.2.4. By Organ
        • 9.4.2.2.5. By Types of Transplant
    • 9.4.3. Canada Organ Transplant Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Sex
        • 9.4.3.2.3. By Product
        • 9.4.3.2.4. By Organ
        • 9.4.3.2.5. By Types of Transplant

10. South America Organ Transplant Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Sex
    • 10.2.3. By Product
    • 10.2.4. By Organ
    • 10.2.5. By Types of Transplant
    • 10.2.6. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Organ Transplant Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Type
        • 10.4.1.2.2. By Sex
        • 10.4.1.2.3. By Product
        • 10.4.1.2.4. By Organ
        • 10.4.1.2.5. By Types of Transplant
    • 10.4.2. Argentina Organ Transplant Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Type
        • 10.4.2.2.2. By Sex
        • 10.4.2.2.3. By Product
        • 10.4.2.2.4. By Organ
        • 10.4.2.2.5. By Types of Transplant
    • 10.4.3. Colombia Organ Transplant Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Type
        • 10.4.3.2.2. By Sex
        • 10.4.3.2.3. By Product
        • 10.4.3.2.4. By Organ
        • 10.4.3.2.5. By Types of Transplant

11. Middle East and Africa Organ Transplant Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Sex
    • 11.2.3. By Product
    • 11.2.4. By Organ
    • 11.2.5. By Types of Transplant
    • 11.2.6. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Organ Transplant Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Type
        • 11.4.1.2.2. By Sex
        • 11.4.1.2.3. By Product
        • 11.4.1.2.4. By Organ
        • 11.4.1.2.5. By Types of Transplant
    • 11.4.2. Saudi Arabia Organ Transplant Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Type
        • 11.4.2.2.2. By Sex
        • 11.4.2.2.3. By Product
        • 11.4.2.2.4. By Organ
        • 11.4.2.2.5. By Types of Transplant
    • 11.4.3. UAE Organ Transplant Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Type
        • 11.4.3.2.2. By Sex
        • 11.4.3.2.3. By Product
        • 11.4.3.2.4. By Organ
        • 11.4.3.2.5. By Types of Transplant

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
      • 14.2.1.1. Novartis
      • 14.2.1.2. Pfizer
      • 14.2.1.3. Transmedics
      • 14.2.1.4. Organ Recovery Systems
      • 14.2.1.5. Sanofi
      • 14.2.1.6. Transonic Systems Inc
      • 14.2.1.7. XVIVO Perfusion
      • 14.2.1.8. Transplant Biomedicals
      • 14.2.1.9. Veloxis Pharmaceuticals A/S
      • 14.2.1.10. Organ Assist B.V
      • 14.2.1.11. Essential Pharmaceuticals LLC.
      • 14.2.1.12. BioLife Solutions, Inc.
      • 14.2.1.13. Lifeline Scientific
      • 14.2.1.14. 21st Century Medicine
      • 14.2.1.15. Preservation solutions Inc
      • 14.2.1.16. GE Healthcare
      • 14.2.1.17. Sandor
      • 14.2.1.18. Glaxosmith Kline
      • 14.2.1.19. AstraZeneca
      • 14.2.1.20. Amgen

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top